TY  - GEN
AU  - Beck,Juliane
AU  - Schwarzer,Andreas
AU  - Gläser,Dietrich
AU  - Mügge,Lars-Olof
AU  - Uhlig,Jens
AU  - Heyn,Simone
AU  - Kragl,Brigitte
AU  - Mohren,Martin
AU  - Hoffmann,Franz Albert
AU  - Lange,Thoralf
AU  - Schliwa,Thomas
AU  - Zehrfeld,Thomas
AU  - Becker,Cornelia
AU  - Kreibich,Ute
AU  - Winkelmann,Cornelia
AU  - Edelmann,Thomas
AU  - Andrea,Marc
AU  - Bill,Marius
AU  - Jentzsch,Madlen
AU  - Schwind,Sebastian
AU  - Niederwieser,Dietger
AU  - Pönisch,Wolfram
TI  - Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077)
SN  - 1432-1335
PY  - 2017///1127
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bendamustine Hydrochloride
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Lenalidomide
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Prednisolone
KW  - Prospective Studies
KW  - Thalidomide
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s00432-017-2504-5
ER  -